CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0
Read more about CPHI

Letrozole Tablets

Letrozole Tablets
Product Description

Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.

Strength: 2.5mg.

Letrozole Tablets is approved by NMPA and EU GMP (Spain and  Netherlands), and have MA issued from US-FDA, Japanese PMDA. It was approved by EU and launched in European market in 2012, approved by US FDA and Launched in American market in May, 2013 and approved to get launched in the Japanese market in 2015.

Read more Show less

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    112809-51-5
More specifications Fewer specifications
Sales Markets
Show more Show less

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
View company profile

More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)

  • Caspofungin Acetate for Injection

    Product Caspofungin Acetate for Injection

    Caspofungin Acetate for Injection, is one of the main products of our company’s anti-infection products’ line which mainly applied in treatment of infection caused by various fungi. 

    Strength: 50mg/vial; 70mg/vial.

    This product is approved by MNPA.
    It is approved by US-FDA, and Ne...
  • Cisatracurium Besylate Injection

    Product Cisatracurium Besylate Injection

    Cisatracurium is used adjunctively inanesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
    Strength: 10mg/5ml; 200mg/20ml (10mg/ml).

    This product has been appr...
  • Cyclophosphamide for Injection

    Product Cyclophosphamide for Injection

    Cyclophosphamide is a medication mainly used in chemotherapy. It is an alkylating agent of the nitrogen mustard type (specifically, the oxazaphosphorine group). It is used to treat cancers, autoimmune disorders and AL amyloidosis. As a prodrug, it is c...
  • Docetaxel Injection

    Product Docetaxel Injection

    It is used  for treatment of locally advanced or metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer.

    Strength: 20mg/1ml; 80mg/4ml;160mg/8ml---US FDA and NMPA approved.
    Strength: 20mg/0.5 ml ...
  • Gabapentin Capsules

    Product Gabapentin Capsules

    Gabapentin is a medication used to treatepilepsy, neuropathic pain, hot flashes, and restless leg syndrome. In epilepsy it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic n...
  • Irinotecan HCl Injection

    Product Irinotecan HCl Injection

    The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.

    Strength: 40mg/2ml; 100mg/5ml.

    NMPA approved.
    MA issued from US-FDA, Japanese PMDA.
  • Oxaliplatin for Injection

    Product Oxaliplatin for Injection

    Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.

    Strength: 50mg/vial.

    It is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.
    MA issued from Spain, Netherlands CBG and UK MH...
  • Fondaparinux Injection

    Product Fondaparinux Injection

    Fondaparinux is an anticoagulant medication chemically related to low molecular weight heparins.
    Strength: 0.5ml:2.5mg; 0.4ml:0.5mg; 0.6ml:7.5mg; 0.8ml:10mg.

    It is approved by US-FDA.
  • Thiotepa for Injection

    Product Thiotepa for Injection

    Thiotepa for Injection USP is an alkylating agentused to treat cancer.

    Strength: 15mg/vial

    Approved by US-FDA.
    Dossiers for EU market have been filed.

  • Lopamidol Injection

    Product Lopamidol Injection

    It is a kind of contrast agent.

    Strength: 
    (300mg iodine/ml) 61% *50ml *100ml  
    (370mg iodine/ml) 76% *50ml *100ml *150ml *200ml


    It is in R&D stage.
  • Tolvaptan HCl Tablets

    Product Tolvaptan HCl Tablets

    It is used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

    Strength: 15mg; 30mg.

    Tolvaptan HCl Tablets have been approved by CFDA...
  • Oxaliplatin Injection

    Product Oxaliplatin Injection

    Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.

    Strength: 50mg/10ml; 100mg/20ml.


    NMPA approved; MA issued from US-FDA.

show all 99 other products

Jiangsu Hengrui Medicine Co., Ltd. resources (3)